Confirms with more detail that there will be a lot happening in all facets of the business in FY24 - news flow should be good in the coming period this year and next half too (noting these can happen at any time).
"Strong pipeline of further commercial agreements expected to be announced in 2023"
"US reimbursement progress well advanced"
FDA submissions for CT:VQ and XV scanner are expected in FY24. Targeting deployment of XV scanner at US based institutions in FY24.
Expanding ANZ - includes their recent focus on targeting adjacent markets that allow Medicare reimbursement.
VA pilot discussions must also be bubbling along too as this is targeted for FY24.
Ann: Investor Presentation, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.015(2.75%) |
Mkt cap ! $229.8M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 57.0¢ | 55.5¢ | $178.2K | 317.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 38625 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 23519 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |